Aprameya Engineering Peer Comparison

NSE: APRAMEYA

₹111.40

₹-2.90 (-2.54%)

As on 08-Oct-2026IST

Market cap

₹212 Cr

Revenue (TTM)

₹55 Cr

P/E Ratio

41.6

P/B Ratio

3.1

Div. Yield

0 %

Edit

	Aprameya Engineering	Poly Medicure	Q-Line Biotech	QMS Medical	Nureca
Market cap (₹ Cr)	212	16,231	1,530	372	316
Revenue (₹ Cr)	55	1,997	342	183	153
Net Profit (₹ Cr)	5.13	307.01	55.72	12.72	4.34
Net Margin (%)	9.22	14.56	16.04	6.90	2.70
RoE (%)	7.67	10.63	25.55	10.39	2.29
Price to Earnings	41.57	51.51	27.45	34.20	72.77
Price-To-Book	3.06	5.10	6.04	--	1.72

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Aprameya Engineering	Poly Medicure	Q-Line Biotech	QMS Medical	Nureca
Operating Revenue	55.13	1,875.26	341.74	--	146.96
Total Income	55.62	2,002.19	347.44	--	155.06
Total Expenditure	44.60	1,436.66	243.64	--	146.78
EBITDA	10.54	438.59	98.10	--	0.18
Depreciation	0.09	115.52	10.79	--	2.02
EBIT	10.44	323.08	87.31	--	-1.84
Interest	3.64	21.42	19.47	--	1.28
Other Income	0.49	126.93	5.70	--	8.10
Exceptional Items	--	-6.80	-0.99	--	--
Profit before Tax	7.29	427.47	72.55	--	4.98
Provision for Tax	2.16	106.74	16.83	--	2.90
Profit after Tax	5.13	320.73	55.72	--	2.08

Liabilities (₹ Cr)

	Aprameya Engineering	Poly Medicure	Q-Line Biotech	QMS Medical	Nureca
Shareholder's Funds	69.40	3,106.17	246.19	--	180.76
Minority Interest	0.18	43.07	--	--	--
Non-Current Liabilities	1.26	120.16	101.51	--	-0.92
Current Liabilities	10.50	666.53	209.92	--	13.78
Total Liabilities	82.27	3,951.60	558.69	--	196.16

Assets (₹ Cr)

	Aprameya Engineering	Poly Medicure	Q-Line Biotech	QMS Medical	Nureca
Non-Current Assets	8.03	1,903.19	213.57	--	78.94
Current Assets	73.30	2,032.74	344.06	--	114.68
Total Assets	82.27	3,951.60	558.69	--	196.16
Total Debt*	7.14	341.62	225.48	--	0.72
Net Current Assets	62.80	1,366.21	134.14	--	100.90
Contingent Liabilities	8.06	50.21	52.55	--	4.73

Cashflow (₹ Cr)

	Aprameya Engineering	Poly Medicure	Q-Line Biotech	QMS Medical	Nureca
Cash From Operating Activities	31.23	246.37	16.38	--	3.30
Cash Flow from Investing Activities	-4.45	-225.38	-29.42	--	14.49
Cash from Financing Activities	-26.66	20.15	41.64	--	-19.56
Net Cash Inflow / Outflow	0.12	41.14	28.60	--	-1.77

Ratios

Profitability Ratios

	Aprameya Engineering	Poly Medicure	Q-Line Biotech	QMS Medical	Nureca
ROCE (%)	12.77	14.05	22.23	--	3.31
ROE (%)	7.67	10.94	25.55	--	1.11
ROA (%)	4.56	8.89	11.01	--	1.04
EBIT Margin (%)	19.99	30.16	30.37	--	5.63
Net Margin (%)	9.22	16.02	16.04	--	1.34
Cash Profit Margin (%)	9.46	23.12	18.40	--	2.57

Growth Ratios

	Aprameya Engineering	Poly Medicure	Q-Line Biotech	QMS Medical	Nureca
Revenue Growth (%)	-59.37	12.30	9.13	--	34.02
EBIT Growth (%)	-55.90	3.80	40.81	--	69.11
Net Profit Growth (%)	-68.18	-5.27	255.32	--	145.86
EPS Growth (%)	-68.34	-4.88	180.69	--	157.91
Book Value Growth (%)	8.00	12.14	29.61	--	-6.96

Valuation Ratios

	Aprameya Engineering	Poly Medicure	Q-Line Biotech	QMS Medical	Nureca
Price / Earnings	76.00	37.47	0.00	--	94.46
Price / Book Value	5.59	3.90	0.00	--	1.09
Dividend Yield (%)	0.00	0.29	--	--	0.00
EV/EBITDA	35.29	21.79	1.59	--	18.84
Market Cap (₹ Cr)	387.75	12,069.92	0.00	--	196.67

Solvency Ratios

	Aprameya Engineering	Poly Medicure	Q-Line Biotech	QMS Medical	Nureca
Debt to Equity	0.10	0.11	0.92	--	0.00
Short term debt to equity ratio	0.06	0.08	0.36	--	0.00
Current Ratio	6.98	3.05	1.64	--	8.32
Quick Ratio	6.73	2.40	1.19	--	4.88
Interest Coverage	3.00	20.96	4.73	--	4.88

Operating Efficiency Ratios

	Aprameya Engineering	Poly Medicure	Q-Line Biotech	QMS Medical	Nureca
Debtors to sales (%)	100.70	28.33	36.82	--	5.27
Asset Turnover	0.49	0.52	0.71	--	0.80
Receivable days	577.64	85.20	105.22	--	12.70
Inventory Days	32.62	69.58	93.48	--	100.27
Payable days	666.27	77.97	146.52	--	22.92
Cash Conversion Cycle	-56.01	76.82	52.17	--	90.04